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BRIEF OBSERVATIONS

Influenza Vaccination
Coverage among Adults
with Asthma: Findings
from the 2000 Behavioral
Risk Factor Surveillance
System
Earl S. Ford, MD, MPH, Seymour G. Williams, MD,
David M. Mannino, MD, Stephen C. Redd, MD

T

he prevalence of asthma has increased substantially in the United States since 1980 (1). The primary clinical and public health strategy to reduce
the burden of asthma is to prevent exacerbation of the
disease, of which upper and lower respiratory tract infections are a major cause (2–5). One such infection—influenza—and its complications are potentially preventable
with annual vaccination, which is a safe and effective
method (6,7), including among persons with asthma (8).
Because persons with asthma are at increased risk of complications from influenza, they are advised to receive annual influenza vaccinations (9), unless there are contraindications.
Little is known about how adults with asthma or health
care providers comply with the annual influenza vaccination recommendations issued by the Advisory Committee on Immunization Practices (9). Among children with
asthma, however, vaccination levels are low (10 –15). We
therefore sought to assess the influenza vaccination coverage among adults with asthma, as well as to identify
predictors of receiving such a vaccination.

METHODS
Data are from the 2000 Behavioral Risk Factor Surveillance System, an annual standardized state-based telephone survey of risk factors for chronic disease (16).
Health agencies in the 50 states, the District of Columbia,
and three U.S. territories (Guam, Puerto Rico, and the
Virgin Islands) selected for interview an independent
probability sample of noninstitutionalized adult residents aged ⱖ18 years who were living households that
had telephones. All states used an identical core questionnaire administered over the telephone by trained interviewers. The survey was reviewed and approved by the
human subjects office at the Centers for Disease Control
and Prevention.
© 2004 by Excerpta Medica Inc.
All rights reserved.

Respondents were asked, “Did a doctor ever tell you
that you had asthma?” Those who responded “yes” were
then asked, “Do you still have asthma?” Respondents who
answered affirmatively to both questions were classified
as having “current” asthma. In 17 states, participants
were also asked, “During the past 12 months, have you
had a flu shot?”
We examined the percentages of participants with
asthma who reported having an influenza vaccination, by
age, sex, race or ethnicity, and education. Direct age adjustment was performed using the age distribution of the
U.S. population in 2000. We used logistic regression analysis to examine the independent associations of age, sex,
race or ethnicity, education, health status, health insurance status, time since the last checkup, and state of origin
with vaccination status. Health status was determined
from the question “Would you say that in general your
health is excellent, very good, good, fair, or poor?” Insurance status was determined from four questions. Time
since the last checkup was determined from the question
“About how long has it been since you last visited a doctor
for a routine checkup?” Answers included the following:
within the past year (1 to 12 months ago), within the past
2 years (1 to 2 years ago), within the past 5 years (2 to 5
years ago), 5 or more years ago, and never.

Statistical Analysis
Analyses were conducted with SUDAAN (Research Triangle Institute, Research Triangle Park, North Carolina)
to produce valid estimates of the variance (17).

RESULTS
From 17 states, we included in our analysis 3939 participants with current asthma who were aged ⱖ18 years and
had complete data. The mean age was 45 years (range, 18
to 96 years); 40% were men; 83% were white; and the
mean length of education was 14 years.
Overall, 41% of participants with asthma reported
having received an influenza vaccination during the preceding year. Influenza vaccination levels were 27%
among participants aged 18 to 49 years, 56% among those
aged 50 to 64 years, and 75% among those aged ⱖ65
years.
In univariate analyses, age, sex, race or ethnicity, health
status, medical insurance, and time since the last physician visit were associated with vaccination status (P ⫽
0.05 for sex; ⬍0.001 for all other variables); education
was not (P ⫽ 0.30). In a multivariate analysis, all of these
univariate associations, except for sex, continued to be
significant (Table 1). In addition, after adjusting for age
(and other variables), higher levels of education were associated with being vaccinated (Table 1).
0002-9343/04/$–see front matter 555
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Table 1. Characteristics Associated with Influenza Vaccination among Persons with Asthma
Variable

Number of
Participants

Number
Vaccinated (%)*

Adjusted Odds Ratio†
(95% Confidence Interval)

2306
900
733

670 (27)
512 (56)
544 (75)

1.0
2.8 (2.1–3.7)
5.0 (3.0–8.4)

1134
2805

472 (37)
1254 (43)

1.0
1.2 (0.9–1.6)

3255
363
169
152

1490 (44)
122 (28)
55 (27)
59 (46)

1.0
0.5 (0.3–0.7)
0.6 (0.4–1.0)
1.0 (0.6–1.9)

569
1212

286 (44)
487 (38)

1.0
1.1 (0.8–1.7)

1188
970

521 (40)
432 (45)

1.6 (1.1–2.4)
2.2 (1.4–3.5)

469
1081
1253
696
440

167 (37)
411 (32)
535 (41)
350 (44)
263 (66)

1.0
0.9 (0.6–1.4)
1.2 (0.8–1.8)
1.3 (0.8–2.1)
2.4 (1.3–4.3)

2320
1008
234
377

911 (36)
673 (66)
82 (40)
60 (18)

1.00
1.4 (0.8–2.2)
1.1 (0.6–1.8)
0.5 (0.3–0.8)

3107
387
196
230
19

1498 (46)
119 (33)
56 (27)
49 (24)
4 (16)

1.0
0.8 (0.5–1.3)
0.6 (0.4–1.2)
0.5 (0.3–0.9)
0.2 (0.0–1.0)

Age (years)
18–49
50–64
ⱖ65
Sex
Male
Female
Race or ethnicity
White
African American
Mexican American
Other
Education
⬍High school
High school/general
equivalency diploma
Some college
Postgraduate
Health status
Excellent
Very good
Good
Fair
Poor
Insurance
Private
Medicare
Medicaid
None
Time since last checkup (years)
⬍1
1–2
2–5
⬎5
Never

* Percentages were calculated using sampling weights. Standard errors range from 2% to 10%.
†
Adjusted for all variables shown in Table.

Influenza vaccination levels varied almost twofold
among the states that had included the influenza vaccination question in their surveys (Table 2): South Dakota
(61%) had the highest coverage and New Jersey (32%)
had the lowest. After adjusting for the variables in Table 1,
these differences among states remained (P ⫽ 0.001).

DISCUSSION
We found that influenza vaccination levels were generally
low among adults with asthma. Only 41% of adults with
asthma reported being vaccinated during the previous
year: 27% of participants aged 18 to 49 years, 56% of
those aged 50 to 64 years, and 75% of those aged ⱖ65
years. Furthermore, there was substantial interstate vari556
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ation in the percentage of participants who were vaccinated. During 1999 to 2001, vaccination levels in the general population ranged from 64% to 68% among people
aged ⱖ65 years and from 32% to 38% among those aged
50 to 64 years (9).
Influenza and asthma are important sources of morbidity and mortality in the United States. Each year,
about 114,000 excess hospitalizations and 36,000 deaths
are attributed to influenza (9). In 1999, about 10.5 million people reported having one or more asthma attacks
during the past 12 months (1). Influenza may be responsible for as many as 19% of asthma attacks or exacerbations in children and adults (2,18,19). Because inactivated influenza vaccine may prevent about 70% to 90% of
influenza illnesses among people aged ⬍65 years during

Influenza Vaccination Coverage among Adults with Asthma/Ford et al

Table 2. Influenza Vaccination Coverage among Persons with Asthma, by State
State

Number of
Participants

Number
Vaccinated (%)*

Adjusted Odds Ratio†
(95% Confidence Interval)

South Dakota
Nebraska
North Dakota
Arizona
Minnesota
South Carolina
Tennessee
North Carolina
Vermont
Iowa
Virginia
California
Ohio
Kansas
Montana
Georgia
New Jersey

274
195
135
198
206
231
233
217
256
227
129
299
263
329
245
258
244

168 (61)
101 (51)
61 (49)
86 (48)
98 (46)
110 (46)
102 (46)
102 (45)
115 (44)
107 (42)
56 (42)
124 (41)
90 (38)
128 (37)
109 (37)
94 (33)
75 (32)

2.9 (1.8–4.7)
1.9 (1.2–3.1)
2.0 (1.1–3.6)
1.6 (0.8–3.0)
1.6 (1.0–2.6)
1.9 (1.2–3.2)
1.3 (0.8–2.2)
1.5 (0.9–2.4)
1.6 (1.0–2.5)
1.4 (0.9–2.3)
1.8 (1.1–3.1)
1.7 (1.1–2.8)
1.3 (0.8–2.1)
1.1 (0.7–1.7)
1.2 (0.7–2.1)
1.1 (0.7–1.9)
1.0 (Reference)

* Percentages were calculated using sampling weights. Standard errors range from 2% to 10%.
†
Adjusted for age, sex, race or ethnicity, education, health status, insurance, and time since last checkup.

the years when the vaccine and circulating influenza
strain match (9), vaccination could substantially reduce
influenza-associated morbidity among persons with
asthma.
Estimating the excess morbidity, mortality, and health
care use among persons with asthma who do not receive
an influenza vaccination is difficult because the benefits
to patients with asthma have not been well established
and the cost-effectiveness of routinely vaccinating people
with asthma is not well defined (20). A recent study
showed that the vaccine effectiveness in reducing hospitalizations for pneumonia and influenza or all-cause
mortality ranged from 27% to 48% among persons aged
ⱖ65 years with lung conditions that included asthma
(21).
Our analysis of data from the Behavioral Risk Factor
Surveillance System shows that 73% of participants with
asthma reported seeing a provider during the past 12
months. For those who do see a health care provider on a
regular basis, opportunities exist for physicians and their
staff to discuss the need for vaccination or to administer
the vaccine. Furthermore, there is a range of patient-,
provider-, and system-specific strategies for improving
vaccination coverage, including sending computerized
reminder letters, implementing patient reminder/recall
systems, and using audit and feedback (22–24). The Centers for Disease Control and Prevention has summarized
strategies for improving vaccination coverage among
adults (25). In addition, physicians may need to address
other concerns about influenza vaccination that are more
specific to persons with asthma, such as effects of the

vaccine while taking inhaled corticosteroids or increased
risk of allergic reactions to vaccine components.
Some of the predictors of vaccination status that we
found, such as age, health status, and medical insurance,
have been described by others (26,27). Thus, to reach
groups with low coverage of influenza vaccination, interventions should be aimed at young adults, African Americans, Mexican Americans, and those without insurance.
The variation in vaccination levels among states suggests
that states with higher levels may employ strategies that
other states could use to improve their vaccination levels.
Several limitations should be considered when interpreting our results. All data were self-reported and subject to misclassification; however, the validity of self-reported asthma (28 –30) and influenza vaccination status
(31–35) has been demonstrated. Because our results are
based on the 17 states that administered the question
about influenza vaccination, these results are not nationally representative. Additionally, the survey did not include institutionalized adults and households without
telephones.
In general, influenza vaccination levels have increased
among adults aged ⱖ65 years in the United States,
although the trend among people with asthma is unknown (9). Should the general favorable trend continue,
progress will be made in achieving the objectives of the
Healthy People 2010, which call for 90% of noninstitutionalized adults aged ⱖ65 years and 60% of noninstitutionalized high-risk adults (including persons with
asthma) aged 18 to 64 years to undergo annual influenza
vaccinations (36).
April 15, 2004
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